Jason J Howard

US Patent:

20140136227, May 15, 2014

Filed:

Jan 15, 2014

Appl. No.:

14/156001

Inventors:

- Kansas City KS, US
HUGH RYAN - LEE'S SUMMIT MO, US
JASON HOWARD - LEE'S SUMMIT MO, US
BHARAT SUTARIYA - PARKVILLE MO, US

Assignee:

CERNER INNOVATION, INC. - Kansas City KS

International Classification:

G06F 19/00

US Classification:

705 2

Abstract:

A readmission risk prediction model is generated and used for identifying patients having elevated risk of readmission and determining inpatient treatment and outpatient activities based on readmission risk. Readmission risk prediction models may be generated for a variety of different clinical conditions using logistic regression techniques. When a patient is admitted to a hospital, the patient's condition is identified and a corresponding readmission risk prediction model is employed to identify the patient's risk of readmission. The readmission risk may be presented to a clinician and employed to recommend interventions intended to treat the patient and reduce the probability of readmission for the patient. The patient's readmission risk may also be calculated after the patient has been discharged and used for planning outpatient activities for the patient.

US Patent:

20120166222, Jun 28, 2012

Filed:

Dec 28, 2010

Appl. No.:

12/979488

Inventors:

Jason Howard - Lee's Summit MO, US
Hugh Ryan - Lee's Summit MO, US

Assignee:

CERNER INNOVATION, INC. - Overland Park KS

International Classification:

G06Q 50/00

US Classification:

705 3

Abstract:

A method, system, medium, and graphical user interface are provided for managing treatment of patients on anticoagulant medications. Patients undergoing anticoagulant treatment are identified. A consolidated list of anticoagulant patients is generated. The list includes patient information, prescribed anticoagulant medications, reasons for treatment, and laboratory test values, among other data. It is determined that a laboratory test result associated with an anticoagulant medication is outside of a desired range. Guidelines associated with provision of the medication are identified and provided to a clinician via a graphical user interface. The GUI provides a centralized consolidated presentation of anticoagulant patient information that allows clinicians to more easily access the information and to more quickly identify activities to be performed for anticoagulant patients. Clinicians may also enter or change orders, document treatment, and receive alerts regarding treatment of anticoagulant patients.

US Patent:

20120016685, Jan 19, 2012

Filed:

Jul 13, 2010

Appl. No.:

12/835376

Inventors:

HUGH RYAN - LEE'S SUMMIT MO, US
JASON HOWARD - LEE'S SUMMIT MO, US
BHARAT SUTARIYA - PARKVILLE MO, US

Assignee:

CERNER INNOVATION, INC. - OVERLAND PARK KS

International Classification:

G06Q 50/00
G06F 3/048

US Classification:

705 2, 715764

Abstract:

Methods, systems, and computer storage media are provided for enabling management of a patient's blood when the patient has a scheduled elective procedure. Blood test results are received for the patient and are recorded in the patient's electronic medical record (EMR). It is determined that the elective procedure is associated with a high risk of blood loss. Based on the blood test results, it is determined that the patient requires blood treatment prior to the elective procedure. Blood treatment instructions are automatically determined and are displayed on the patient's EMR such that the clinician associated with the patient can review the instructions and determine if the patient will receive any or all of the recommended blood treatment prior to the elective procedure.

US Patent:

20120016686, Jan 19, 2012

Filed:

Jul 13, 2010

Appl. No.:

12/835433

Inventors:

HUGH RYAN - LEE'S SUMMIT MO, US
JASON HOWARD - LEE'S SUMMIT MO, US
BHARAT SUTARIYA - PARKVILLE MO, US

Assignee:

CERNER INNOVATION, INC. - OVERLAND PARK KS

International Classification:

G06Q 50/00

US Classification:

705 2

Abstract:

Methods, systems, and computer storage media are provided for enabling management of a patient's blood when the patient has been admitted to a healthcare facility but does not have a scheduled procedure. A patient who is admitted to the healthcare facility is identified and based on the patient's red blood cell measurements, it is determined that the patient is anemic. It is determined that the patient requires blood treatment based on these red blood cell measurements. Blood treatment instructions are determined by way of algorithms, and these instructions are displayed in the patient's electronic medical record such that a clinician can determine, based on the recommended instructions, which interventions to administer to the patient.

US Patent:

20110313788, Dec 22, 2011

Filed:

Jun 17, 2010

Appl. No.:

12/817602

Inventors:

ROBERT CHARLES AMLAND - LENEXA KS, US
HUGH RYAN - LEE'S SUMMIT MO, US
JASON HOWARD - LEE'S SUMMIT MO, US
BHARAT SUTARIYA - PARKVILLE MO, US

Assignee:

CERNER INNOVATION, INC. - OVERLAND PARK KS

International Classification:

G06Q 50/00
G06N 7/02
G06Q 10/00

US Classification:

705 3, 706 52

Abstract:

A readmission risk prediction model is generated and used for identifying patients having elevated risk of readmission and determining inpatient treatment and outpatient activities based on readmission risk. Readmission risk prediction models may be generated for a variety of different clinical conditions using logistic regression techniques. When a patient is admitted to a hospital, the patient's condition is identified and a corresponding readmission risk prediction model is employed to identify the patient's risk of readmission. The readmission risk may be presented to a clinician and employed to recommend interventions intended to treat the patient and reduce the probability of readmission for the patient. The patient's readmission risk may also be calculated after the patient has been discharged and used for planning outpatient activities for the patient.